Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Emily Yoshioka, Danielle Giovenco, Caroline Kuo, Kristen Underhill, Jackie Hoare & Don Operario. (2020) “I’m doing this test so I can benefit from PrEP”: exploring HIV testing barriers/facilitators and implementation of pre-exposure prophylaxis among South African adolescents. African Journal of AIDS Research 19:2, pages 101-108.
Read now
Read now
Mance E. Buttram. (2018) The informal use of antiretroviral medications for HIV prevention by men who have sex with men in South Florida: initiation, use practices, medications and motivations. Culture, Health & Sexuality 20:11, pages 1185-1198.
Read now
Read now
Kebede Beyene, Trudi Aspden & Janie Sheridan. (2016) Prescription medicine sharing: exploring patients’ beliefs and experiences. Journal of Pharmaceutical Policy and Practice 9:1.
Read now
Read now
Articles from other publishers (26)
Caitlin E. Kennedy, Xinyi Feng, Robert Ssekubugu, Joseph G. Rosen, Joseph Ssekasanvu, Godfrey Kigozi, David Serwadda, Ping Teresa Yeh, Joseph Kagaayi, Thomas C. Quinn, Aaron A. R. Tobian, Maria J. Wawer, Steven J. Reynolds, Larry W. Chang, M. Kate Grabowski & Fred Nalugoda. (2023) Population prevalence of antiretroviral therapy sharing and its association with HIV viremia in rural Uganda: a cross‐sectional population‐based study. Journal of the International AIDS Society 26:9.
Crossref
Crossref
Jeff Lane, Audrey Brezak, Pragna Patel, Andre R. Verani, Irene Benech & Aaron Katz. (2021) Policy considerations for scaling up access to HIV pre‐exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda. The International Journal of Health Planning and Management 36:5, pages 1789-1808.
Crossref
Crossref
Marisa Felsher, Eliza Ziegler, K. Rivet Amico, Adam Carrico, Jennie Coleman & Alexis M. Roth. (2021) “PrEP just isn't my priority”: Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Social Science & Medicine 275, pages 113809.
Crossref
Crossref
Buyisile Chibi, Nonhlanhla Yende-Zuma & Tivani P. Mashamba-Thompson. (2020) Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa. PLOS ONE 15:12, pages e0243718.
Crossref
Crossref
Hong-Van Tieu, Beryl A. Koblin, Carl Latkin, Frank C. Curriero, Emily R. Greene, Andrew Rundle & Victoria Frye. (2018) Neighborhood and Network Characteristics and the HIV Care Continuum among Gay, Bisexual, and Other Men Who Have Sex with Men. Journal of Urban Health 97:5, pages 592-608.
Crossref
Crossref
Caroline Kuo, Danielle Giovenco, Teresa DeAtley, Jackie Hoare, Kristen Underhill, Millicent Atujuna, Catherine Mathews, Dan J. Stein, Larry K. Brown & Don Operario. (2020) Recreational Use of HIV Antiretroviral Medication and Implications for HIV Pre-exposure Prophylaxis and Treatment. AIDS and Behavior 24:9, pages 2650-2655.
Crossref
Crossref
Emiko Kamitani, Wayne D. Johnson, Megan E. Wichser, Adebukola H. Adegbite, Mary M. Mullins & Theresa Ann Sipe. (2020) Growth in Proportion and Disparities of HIV PrEP Use Among Key Populations Identified in the United States National Goals: Systematic Review and Meta-analysis of Published Surveys. JAIDS Journal of Acquired Immune Deficiency Syndromes 84:4, pages 379-386.
Crossref
Crossref
Buyisile Chibi, Neusa F. Torres, Zinhle P. Sokhela & Tivani P. Mashamba-Thompson. (2020) Risk factors for prescription drug diversion among people living with HIV: a systematic scoping review. International Journal of Evidence-Based Healthcare 18:1, pages 5-23.
Crossref
Crossref
B. Chibi, N.F. Torres, Z.P. Sokhela & T.P. Mashamba-Thompson. (2019) Prescription drug diversion among people living with HIV: a systematic scoping review. Public Health 177, pages 26-43.
Crossref
Crossref
Mance E. Buttram & Steven P. Kurtz. (2018) Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men. AIDS and Behavior 23:7, pages 1790-1796.
Crossref
Crossref
Heather Farthing, Anamaria Rodriguez, Misha Armstrong, Siddharth Iyengar, Evan Nigh, JoNell Potter & Susanne Doblecki-Lewis. (2018) Discomfort discussing HIV/AIDS and lack of awareness are barriers to partner-to-partner pre-exposure prophylaxis education. International Journal of STD & AIDS 30:2, pages 147-153.
Crossref
Crossref
Kristen Underhill, Kate M. Guthrie, Christopher Colleran, Sarah K. Calabrese, Don Operario & Kenneth H. Mayer. (2018) Temporal Fluctuations in Behavior, Perceived HIV Risk, and Willingness to Use Pre-Exposure Prophylaxis (PrEP). Archives of Sexual Behavior 47:7, pages 2109-2121.
Crossref
Crossref
Nazia Qureshi, Marjan Javanbakht, Martha Tadesse, Mark Malek & Garrett Cox. (2018) Risk-Based HIV Testing at Los Angeles County Men’s Central Jail. Journal of Correctional Health Care 24:3, pages 309-319.
Crossref
Crossref
Mohamed A. Hammoud, Stefanie Vaccher, Fengyi Jin, Adam Bourne, Bridget Haire, Lisa Maher, Toby Lea & Garrett Prestage. (2018) The new MTV generation: Using methamphetamine, Truvada™, and Viagra™ to enhance sex and stay safe. International Journal of Drug Policy 55, pages 197-204.
Crossref
Crossref
Lisa A. Eaton, Derrick D. Matthews, Daniel D. Driffin, Leigh Bukowski, Patrick A. Wilson & Ron D. Stall. (2017) A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men. Prevention Science 18:5, pages 505-516.
Crossref
Crossref
Kerry A. Thomson, Jessica E. Haberer, Mark A. Marzinke, Andrew Mujugira, Craig W. Hendrix, Connie Celum, Patrick Ndase, Allan Ronald, David R. Bangsberg & Jared M. Baeten. (2017) Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes 75:2, pages 184-189.
Crossref
Crossref
Mance E. Buttram & Steven P. Kurtz. (2017) Preliminary evidence of HIV seroconversion among HIV-negative men who have sex with men taking non-prescribed antiretroviral medication for HIV prevention in Miami, Florida, USA. Sexual Health 14:2, pages 193.
Crossref
Crossref
Steven P. KurtzMance E. Buttram. (2016) Misunderstanding of Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men: Public Health and Policy Implications. LGBT Health 3:6, pages 461-464.
Crossref
Crossref
Jeeva Moodley, Sarita Naidoo, Jayajothi Moodley & Gita Ramjee. (2016) Sharing of Investigational Drug Among Participants in the Voice Trial. AIDS and Behavior 20:11, pages 2709-2714.
Crossref
Crossref
Tanya L. Kowalczyk MullinsGregory ZimetMichelle LallyJessica A. Kahn. (2016) Adolescent Human Immunodeficiency Virus Care Providers’ Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth. AIDS Patient Care and STDs 30:7, pages 339-348.
Crossref
Crossref
Vorapot Sapsirisavat, Vorasit Vongsutilers, Narukjaporn Thammajaruk, Kanitta Pussadee, Prakit Riyaten, Stephen Kerr, Anchalee Avihingsanon, Praphan Phanuphak & Kiat Ruxrungtham. (2016) Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study – PEDA Study. PLOS ONE 11:6, pages e0157039.
Crossref
Crossref
Iris Chen, William Clarke, San-San Ou, Mark A. Marzinke, Autumn Breaud, Lynda M. Emel, Jing Wang, James P. Hughes, Paul Richardson, Danielle F. Haley, Jonathan Lucas, Anne Rompalo, Jessica E. Justman, Sally L. Hodder & Susan H. Eshleman. (2015) Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. PLOS ONE 10:10, pages e0140074.
Crossref
Crossref
Iris Chen, Matthew B. Connor, William Clarke, Mark A. Marzinke, Vanessa Cummings, Autumn Breaud, Jessica M. Fogel, Oliver Laeyendecker, Sheldon D. Fields, Deborah Donnell, Sam Griffith, Hyman M. Scott, Steven Shoptaw, Carlos del Rio, Manya Magnus, Sharon Mannheimer, Darrell P. Wheeler, Kenneth H. Mayer, Beryl A. Koblin & Susan H. Eshleman. (2015) Antiretroviral Drug Use and HIV Drug Resistance Among HIV-Infected Black Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes 69:4, pages 446-452.
Crossref
Crossref
Kiyomi Tsuyuki & Hilary L. Surratt. (2015) Antiretroviral Drug Diversion Links Social Vulnerability to Poor Medication Adherence in Substance Abusing Populations. AIDS and Behavior 19:5, pages 869-881.
Crossref
Crossref
Kiyomi Tsuyuki, Hilary L. Surratt, Maria A. Levi-Minzi, Catherine L. O’Grady & Steven P. Kurtz. (2014) The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations. AIDS and Behavior 19:5, pages 857-868.
Crossref
Crossref
Albert Liu, Stephanie Cohen, Stephen Follansbee, Deborah Cohan, Shannon Weber, Darpun Sachdev & Susan Buchbinder. (2014) Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco. PLoS Medicine 11:3, pages e1001613.
Crossref
Crossref
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112448/MPU-L1SN.png"})